Market Place
Sourcing Support
Ipsen`s CBO is on a $3B mission to get the company `back on the right track`
27 Oct 2021 //
ENDPTS
Ipsen scraps pivotal trial as partial clinical hold drags on
26 Mar 2020 //
FIERCE BIOTECH
Revenue growth at Ipsen numbs pain of palovarotene calamity
14 Feb 2020 //
PMLIVE
Ipsen bags Blueprint drug to move deeper into ultra-rare disease
16 Oct 2019 //
FIERCE BIOTECH
Clementia Pharma Obtains Interim Order for Proposed Transaction With Ipsen
07 Mar 2019 //
PR NEWSWIRE
Ipsen buys rare disease group Clementia in $1.3bn deal
26 Feb 2019 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.